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Abstract
Objective To examine the prevalence of a risk of bias
associated with the design and conduct of cluster
randomised controlled trials among a sample of
recently published studies.
Design Retrospective review of cluster randomised
trials published in the BMJ, Lancet, and New England
Journal of Medicine from January 1997 to October
2002.
Main outcome measures Prevalence of secure
randomisation of clusters, identification of
participants before randomisation (to avoid
foreknowledge of allocation), differential recruitment
between treatment arms, differential application of
inclusion and exclusion criteria, and differential
attrition.
Results Of the 36 trials identified, 24 were published
in the BMJ, 11 in the Lancet, and a single trial in the
New England Journal of Medicine. At the cluster level, 15
(42%) trials provided evidence for secure allocation
and 25 (69%) used stratified allocation. Few trials
showed evidence of imbalance at the cluster level.
However, some evidence of susceptibility to risk of
bias at the individual level existed in 14 (39%) studies.
Conclusions Some recently published cluster
randomised trials may not have taken adequate
precautions to guard against threats to the internal
validity of their design.
Introduction
In most clinical trials participants are randomised as
individuals to different treatments. Sometimes indi-
vidual allocation is not possible or desirable, and
groups of individuals are randomised instead: this is
known as cluster or group randomisation. Many
reasons for using cluster allocation exist. For example,
evaluation of clinical guidelines or medical education
on patient outcomes almost always requires that
healthcare professionals are the “unit” of allocation.
Although randomised trials are the most robust
evaluative method, poorly conducted studies are
susceptible to different forms of selection bias that can
make their results unsound. Methodological reviews of
individually randomised trials have shown that
rigorously conducted trials produce different effect
estimates from poorly conducted studies.1 2 Less atten-
tion has been paid, however, to cluster trials. Cluster
trials are generally more difficult to design and execute
than individually randomised studies, and some design
features of a cluster trial may make it especially vulner-
able to a range of threats that can introduce selection
bias.
In cluster trials potential bias in the execution of
the trial can occur at two levels, the first of which is the
cluster level. Randomisation of clusters needs to be
undertaken carefully and preferably independently.
Otherwise, biased allocation may occur (certain
clusters being allocated to a particular arm on the basis
of reasons that might affect outcome). It is theoretically
possible for allocation of clusters to be subverted, as
has happened in individually randomised trials.3 Simi-
larly, once clusters have been allocated it is important,
as with individually randomised trials, to try to retain
the cluster in its allocated group and avoid the cluster
dropping out, to avoid the risk of attrition bias.
The second level at which bias can occur in cluster
trials is after the clusters have been allocated and when
individual participants are recruited into the study.
Sometimes identification and recruitment of partici-
pants and assessment of outcome in a cluster trial are
relatively straightforward with little scope for bias. For
example, in an evaluation of the effect of offering rou-
tine influenza vaccination to healthcare workers on
patient mortality, hospitals were randomised to offer
routine vaccination to staff or not.w1 Any differences
between the groups were then observed by using mor-
tality data. Two important methodological aspects to
this trial, and other similar cluster trials, limit the risk of
bias. These are complete identification and inclusion of
participants, partly owing to the fact that consent was
not needed for either treatment or collection of data.
Because all the participants were identified and
included at the point of randomisation, except for
chance imbalances the two groups should be similar at
baseline (assuming that the allocation procedure was
fair), which avoids the threat of selection bias.
In some cluster trials identification and inclusion of
participants and assessment of outcome are less
straightforward. Often participants have to be recruited
prospectively after randomisation. For example, in a trial
of the effectiveness of a training package for general
practitioners, patients had to be identified prospectively
after the general practitioner had been randomised.w2
The prospective inclusion of participants can potentially
lead to selection bias through the recruitment of differ-
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ent types of participant by the researcher or clinician. If
the person prospectively recruiting participants has
“foreknowledge” of the allocation group then, as shown
in individually randomised trials, bias can result.3 In
addition to this source of selection bias, another can be
introduced by the participant if consent is needed after
randomisation.
Selection bias can be introduced if consent is
withheld for either treatment or data collection. This is
a well known disadvantage of acquiring consent after
randomisation in individually randomised trials
(known as Zelen’s method4), because some refusal of
treatment or data collection will usually occur.5 This is
less of a problem in non-Zelen designs, as participants
are told in advance about the treatment options and if
they decline to be exposed to one of the options
they are not randomised (although some may decline
in the period between allocation and receipt of
treatment).
Several ways of avoiding the biases outlined above
exist. One is to try to identify trial participants before
randomisation and obtain consent for treatment, data
collection, or both before allocation. Use of prior iden-
tification and prior consent avoids potential biases
occurring through foreknowledge of the allocation
schedule, by the researcher and patient. If this is not
possible, identification and recruitment of participants
should ideally be undertaken by someone blinded to
the group allocation.
Another problem that can lead to bias, in both
individual and cluster randomised trials, is the
differential application of inclusion and exclusion
criteria. Differential exclusion between groups in an
individually randomised trial of breast cancer screen-
ing, identified in a systematic review, has led to
questions about its rigour.6 Again this problem can be
reduced if the person applying the criteria is blinded to
the group allocation.
In this paper we review some recently published
cluster trials to determine the extent of their risk of
bias. We also describe the steps that some authors took
to reduce these risks.
Methods
Searching and data extraction
We hand searched the BMJ, Lancet, and New England
Journal of Medicine for all cluster randomised trials
published from January 1997 to October 2002. We
based our choice of journals on anecdotal experience
that the BMJ regularly publishes cluster trials, as does
the Lancet, and a wish to include a non-British general
medical journal. We limited our search to five years
merely so that we had a sample of fairly recent trials.
We did not have a predetermined sample size.
Table 1 Characteristics of included cluster trials
Study
No of
clusters
No of
participants Description
Clustering accounted for in
sample size estimation?
Aveyard 1999w3 52 9 301 Expert system for smoking prevention and cessation in schools Yes
Bennewith 2002w4 98 2 141 Prevention of repeat episodes of deliberate self harm Yes
Carman 2000w1 20 1 437 Influenza vaccination of healthcare workers Yes
Chapman 2000w5 8 346 Educational intervention to prevent dog bites No
Field 2001w6 9 494 Two methods of data collection Yes
Flottorp 2002w7 142 12 369 To improve general practice management of sore throat and urinary tract infections Yes
Gavgani 2002w8 18 4 498 Insecticide impregnated dog collars on incidence of zoonotic visceral leishmaniasis No
Graham 2002w9 24 3 794 Teenagers’ knowledge of emergency contraception Yes
Haider 2000w10 40 726 Community based peer counsellors on breast feeding Not clear
Jolly 1999w11 67 686 Programme to coordinate and support follow up care in general practice Not clear
Jordhoy 2000w12 6 707 Palliative care intervention Not clear
Kannus 2000w13 22 1 725 Hip protectors No
Kendrick 1999w14 36 2 152 Prevent unintentional injuries in children Yes
Kidane 2000w15 37 70 506 Maternal education for early treatment of paediatric malaria Yes
King 2002w2 116 410 Behavioural therapy to treat patients with depression Yes
Kinmonth 1998w16 43 360 Patient centred care for diabetes in general practice Yes
Kroeger 2002w17 14 2 913 Insecticide impregnated curtains to control transmission of cutaneous leishmaniasis No
MacArthur 2002w18 37 3 580 Community postnatal care Yes
McCartney 1997w19 28 182 200 General practitioner feedback to increase aspirin use No
Moher 2001w20 21 2 142 Secondary prevention of coronary heart disease Yes
Montgomery 2000w21 27 810 Interventions for management of hypertension Yes
Morrison 2001w22 221 689 Infertility guidelines for general practitioners Yes
Morrow 1999w23 39 130 Home based counselling to promote breast feeding Yes
O’Cathain 2002w24 13 10 327 Leaflets to promote informed choice in maternity care Yes
Olivarius 2001w25 311 1 470 Structured personal care of type 2 diabetes mellitus No
Premaratne 1999w26 40 48 800 Effectiveness of an asthma resource centre No
Sagliocca 1999w27 146 404 Hepatitis A vaccine No
Sahota 2001w28 10 636 School intervention to reduce risk factors for obesity Yes
Shah 2001w29 6 325 Peer led programme for asthma education in adolescents No
Smeeth 2001w30 106 42 278 Methods to administer a screening questionnaire No
Steptoe 1999w31 20 883 Behavioural counselling in general practice Yes
Thompson 2000w32 59 4 192 Detection and outcome of depression in primary care Yes
Van Eijk 2001w33 21 46 078 Academic detailing to reduce antidepressant use No
Wawer 1999w34 10 44 107 Prevention of sexually transmitted disease No
West 1999w35 270 44 646 Supplementation with vitamin A or  carotene on mortality related to pregnancy No
Wight 2000w36 25 8 430 Teacher delivered sex education Yes
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Definition of outcomes
Selection bias can be introduced into a trial in several
different ways. In this paper we sought evidence for the
risk of bias from several sources.
Secure cluster allocation—This is where evidence exists
that cluster randomisation was securely undertaken.
Cluster attrition—This occurs when clusters are lost
to follow up after randomisation.
Cluster imbalance—This is where evidence exists of
imbalance in important variables at the cluster level.
Differential individual recruitment or consent—This is
when different proportions of participants are
recruited to the different arms of the trial. If
recruitment rates differ between groups this may lead
to the risk of bias.
Differential individual exclusion or inclusion—This can
occur when eligibility criteria are applied differentially
after randomisation, which can introduce bias.
Two of us (SP, JW) hand searched the journals and
independently extracted data. The three authors met
to discuss all the papers and any disagreements. If we
observed differences in proportions between the
randomised groups in recruitment, consent, and exclu-
sion or inclusion rates we used 2 to test for
significance.
Results
We identified 42 potentially eligible trials. We excluded
six studies: one was a 14 year follow up of an earlier
trial,7 another measured the intervention and outcome
on only one level,8 another had a switchback design,9
two guideline studies did not provide any data on indi-
vidual participants,10 11 and the sixth trial had a mixture
of cluster and individual allocation.12 Of the 36 trials
included,w1-w36 24 were published in the BMJ, 11 in the
Lancet, and one in the New England Journal of Medicine.
In table 1 we describe the basic characteristics of the
trials. In table 2 we examine whether the trials
identified participants before random allocation and
any evidence of bias occurring in the trials.
Secure cluster allocation—Fifteen trials seemed to use
a secure method of allocating clusters; the remainder
did not clearly describe who undertook the allocation
(table 2) or how this was done. Most trials used some
form of stratified random allocation to reduce the
possibility of “chance bias.”
Cluster attrition—In 10 trials a loss of clusters
occurred between randomisation and follow up. Most
of the trials lost only a small proportion of their
Table 2 Potential sources of bias
Study
Did cluster
allocation
seem secure?
Cluster
allocation
stratified?
Evidence of
cluster
imbalance?
How many clusters
lost after
randomisation?
Patients
identified before
randomisation?
Could selection
have been biased?
Evidence of risk
of bias?
Aveyard 1999w3 Yes Yes No 1 Yes No No
Bennewith 2002w4 Yes Yes No 1 No No No
Carman 2000w1 Yes Yes Yes 0 Yes No No/Yes*
Chapman 2000w5 Unclear Unclear Yes 0 No No No
Field 2001w6 Yes Yes No 0 No Yes No
Flottorp 2002w7 Yes No No 22 Yes No No
Gavgani 2002w8 Unclear Yes No 0 Yes No Attrition
Graham 2002w9 Yes Yes Unclear 0 Yes Yes Consent
Haider 2000w10 Unclear No Unclear 0 No Yes No
Jolly 1999w11 Yes Yes Unclear 0 No Yes Recruitment
Jordhoy 2000w12 Unclear Yes Unclear 0 No Yes No
Kannus 2000w13 Unclear No Unclear 0 Yes Yes Consent
Kendrick 1999w14 Yes Yes Unclear 0 Unclear Unclear No
Kidane 2000w15 Unclear Yes Unclear 0 Yes No No
King 2002w2 Unclear No No 32 No No No
Kinmonth 1998w16 Yes Yes No 2 No Yes Recruitment
Kroeger 2002w17 Yes Yes No 1 Yes No No
MacArthur 2002w18 Yes Yes Unclear 1 No Yes Attrition
McCartney 1997w19 Unclear Unclear No 0 Yes No No
Moher 2001w20 Yes Yes No 0 Yes Yes Exclusion
Montgomery 2000w21 Yes Yes Unclear 0 No No No
Morrison 2001w22 Unclear Yes No 7 No Yes No
Morrow 1999w23 Yes Yes Unclear 8 No Yes No
O’Cathain 2002w24 No Yes Unclear 0 No Yes No
Olivarius 2001w25 Unclear Yes No 10 No Yes Exclusion
Premaratne 1999w26 Unclear Yes No 0 No No No
Sagliocca 1999w27 Unclear No Unclear 0 No No Attrition
Sahota 2001w28 No Yes Unclear 0 Yes No No
Shah 2001w29 Unclear No Yes 0 No No Inclusion
Smeeth 2001w30 Unclear Unclear Unclear 0 Yes No No
Steptoe 1999w31 Unclear Yes No 0 No Yes Recruitment
Thompson 2000w32 Yes Yes Unclear 4 No Yes No
Van Eijk 2001w33 Unclear Unclear No 0 Yes No No
Wawer 1999w34 Unclear Yes No 0 Yes No Consent
West 1999w35 Unclear Yes No 0 No Unclear No
Wight 2002w36 Unclear Unclear No 0 Unclear No Attrition
*Not for main outcome, possibly for secondary outcome.
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clusters, but one study lost more than half (56%) of all
the randomised clusters.w2
Differential consent or recruitment—We found some
evidence for differential consent or recruitment in
seven of the 23 trials that had not undertaken prior
identification of participants (table 2). Three trials
recruited more participants from one group than the
other,w11 w16 w31 and the other four studies differentially
obtained consent from more participants in one arm
than the other.w9 w13 w29 w34 One trial, although it seemed
to identify all the participants before allocation for the
main mortality outcome, seemed to have introduced
the risk of selection bias into the measurement of its
secondary outcome.w1
Differential application of inclusion or exclusion
criteria—We found two trials that seemed to have
applied inclusion or exclusion criteria differentially
between groups after randomisation.w20 w25 Moher et al,
in a study promoting methods of secondary preven-
tion of coronary disease, excluded significantly more
participants owing to misdiagnosis in the intervention
groups than in the control group.w20 Similarly, Olivarius
et al excluded twice as many participants because of ill-
ness in the intervention group than in the control
arm.w25
Differential attrition—Evidence of differential attri-
tion between the randomised groups existed in four
trials.w8 w18 w27 w36
Table 3 summarises the potential sources of bias
risk in 14 trials in which we observed differences
between the groups that indicate a risk of selection
bias. Authors of six studies alerted the reader to the
potential risk of bias in their study.
Discussion
Cluster trials can be difficult to do; nevertheless, they
are needed to evaluate some interventions. Although a
large literature exists about sources of potential bias
that can occur in individually randomised trials, less
evidence is available about the special problems
encountered in cluster trials.
Evidence of bias risk at cluster level
Some authors did not clearly describe the allocation
process of the clusters, which is important as this can
be subverted; other trialists were clear in stating that an
independent person undertook the allocation. In most
trials some form of stratification was used to reduce the
element of chance bias, although this was not always
successful. Some trials lost complete clusters after
randomisation. However, with the exception of one
trial,w2 the proportion of clusters lost was relatively low
and therefore would be unlikely to introduce bias.
Evidence of bias risk at individual level
One of the major risks for introduction of bias is when
prospective recruitment is needed. This difficulty can
be overcome and the risk of bias reduced, as two exam-
ples serve to illustrate. Bennewith et al reduced the
possibility of recruitment bias by blinding the clinician
identifying participants until after the patient was
assessed as being eligible or not.w4 Similarly, King et al
reduced the same threat by asking a trained reception-
ist to recruit patients.w2 Because that trial evaluated a
training package to help general practitioners to man-
age depressed patients, the training would probably
have reduced the diagnostic threshold of the general
practitioners. Thus, had the doctors recruited partici-
pants themselves, this would have increased the risk
that they could have recruited either more or less seri-
ously depressed participants than the control doctors.
Use of receptionists reduced this risk.
As well as differences between groups in recruit-
ment and consent, we found that differential
post-randomisation exclusion or inclusion was a prob-
lem in some studies. Inclusion of the “wrong”
participant is likely to be a problem in some cluster
trials. Two ways exist to deal with wrong inclusions and
avoid bias. Firstly, all participants could be retained
within the trial after allocation whether or not they fit-
ted the inclusion criteria and even if they could not or
did not receive the allocated treatment (that is,
intention to treat analysis).13 This could lead, however,
to some dilution of treatment effect. As an alternative,
Table 3 Evidence of risk of bias
Study Potential source of bias
Acknowledgment of risk
by authors and steps taken
Carmen 2000w1 48% v 33% of patients having influenza vaccination, P<0.01; 69% (258/375) v 78% (269/344) accepted
virological screening for secondary outcome assessment, P=0.004
Yes, for cluster imbalance, used adjusted odds ratios
Gavgani 2002w8 7.6% (143/1870) v 11.4% (229/2006) attrition in control and intervention groups, P<0.001 No
Graham 2002w9 12.2% (216/1768) of control group refused consent v 17% (344/2026) of intervention group, P<0.001 No
Jolly 1999w11 Control group recruited 15.5% more than intervention group; practice population not given, so impossible to
see if significantly different
Noted recruitment “imbalance” in discussion
Kannus 2000w13 31.4% (204/650) of intervention group refused consent v 8.7% (94/1075) of control group, P<0.001 Acknowledged potential for selection bias in discussion
Kinmonth 1998w16 0.06% (142/225 015) v 0.047% (108/230 560) of practice populations were recruited for intervention and
control groups, P=0.02
No
MacArthur 2002w18 4.2% (46/1087) v 2.6% (25/977) of intervention and control groups withdrew or moved away, P=0.04 Commented on loss to follow up in discussion
Moher 2001w20 0.32% (2/623) v 2.6% (20/772) and 1.3% (10/747) misdiagnoses for control and two intervention groups,
P=0.002
No
Olivarius 2001w25 8.7% (67/774) v 4.0% (28/696) excluded owing to illness in intervention group and control group, P<0.01 Noted in results more post-randomisation exclusions
Sagliocca 1999w27 3.9% (7/178) v 0% (0/173) lost to follow up in control and intervention groups, P=0.02 No
Shah 2001w29 22.3% (148/662) v 17.3% (124/717) included in control and intervention groups, P=0.02 No
Steptoe 1999w31 Control practices recruited 567 v 316 participants given similar sized populations (P value not calculable) Differential recruitment rate mentioned in discussion,
but not as a potential source of bias
Wawer 1999w34 17.5% (4002/22 915) v 14.7% (3125/21 192) refused consent or treatment in intervention and control groups,
P<0.001
No
Wight 2002w36 30.6% (1070/3493) v 27.5% (1069/3892) attrition in numbers reporting intercourse in intervention and control
groups, P=0.003
No
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decisions on exclusion could be made by a person
blind to the group allocation.
A new CONSORT statement?
Elbourne and Campbell have recently argued for
amending the CONSORT statement to allow for the
special methodological circumstances of cluster trials.14
We would echo this call. We found it very difficult in
several of the trials to ascertain whether a risk of bias
was likely or not. We would wish the following
additions to be made. Firstly, a clear statement as to
whether the population was identified before or after
the allocation decision had been made. Secondly, was
the person who recruited the participants blind to
group allocation? Thirdly, what was the size of the
population within the clusters? For example, Steptoe et
alw31 did not state the size of the general practice popu-
lations in their trial arms and Kinmonth et alw15 gave
only means. For the first of these studies we could only
assume that the recruitment was significantly different,
and for the second study we had to make an estimate.
This missing information also meant that for some
studies we could not be completely sure if recruitment
bias had taken place. For example, in Kendrick et al no
suggestion of any recruitment bias was apparent; how-
ever, we could not be absolutely sure as the authors did
not present the practice population sizes.w14
Conclusion
Cluster trials are vulnerable to the risk of bias. Careful
planning and execution of such trials can avoid these
biases.
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What is already known on this topic
Reviews of individually randomised trials show
that results can differ according to quality of
methods
Foreknowledge of allocation and failure to use
intention to treat analysis can lead to bias
What this study adds
Cluster randomised trials are susceptible to forms
of selection bias
Careful planning and execution of such trials can
avoid these biases
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